Please assess the completion status of the following clinical trial:

Trial Title: A Dose-ranging Study to Evaluate Albuterol and Hydrofluoroalkane in Subjects Ages 12 and Older With Persistent Asthma

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: PHASE2
- Number of Arms: 5.0

Eligibility Criteria:
Inclusion Criteria:~* Must provide written informed consent,~* Be between 12 years of age and older,~* Male or Female, females of non-child bearing potential or using reliable contraception~* Asthma for at least 6 months, FEV1 (forced expiratory volume in 1 second) between 50-80% of predicted value, and reversibility greater than or equal to 15% following 180 mcg albuterol~* Stable low dose of Inhaled Corticosteroids~* Non-smoker, 12 months smoking-free and \<=10-pack years history~* Otherwise healthy~* Other criteria apply~Exclusion Criteria:~* Pregnant~* Allergic to albuterol or severe milk protein allergy~* Must not be on another trial for 30days.~* Other criteria apply

- Gender: ALL
- Minimum Age: 12 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Albuterol Spiromax® 90 mcg (Type: EXPERIMENTAL): A single dose of albuterol 90 mcg delivered with Spiromax®, an inhalation-driven, multi-dose dry powder inhaler. Placebo inhalers used to maintain the blind.
- Albuterol Spiromax® 180 mcg (Type: EXPERIMENTAL): A single dose of albuterol 180 mcg delivered with Spiromax®, an inhalation-driven, multi-dose dry powder inhaler (2 inhalations). Placebo inhalers used to maintain the blind.
- ProAir® HFA 90 mcg (Type: ACTIVE_COMPARATOR): A single dose of albuterol 90 mcg delivered with ProAir®, a 'press-and-breathe', metered-dose, aerosol inhaler. Placebo inhalers used to maintain the blind.
- ProAir® HFA 180 mcg (Type: ACTIVE_COMPARATOR): A single dose of albuterol 180 mcg delivered with ProAir®, a 'press-and-breathe', metered-dose, aerosol inhaler (2 inhalations). Placebo inhalers used to maintain the blind.
- Placebo Inhaler (Type: PLACEBO_COMPARATOR): Placebo delivered with Spiromax®, an inhalation-driven, multi-dose dry powder inhaler, and with ProAir®, a 'press-and-breathe', metered-dose, aerosol inhaler. Placebo inhalers used to maintain the blind.

Based on this trial design, predict the completion outcome and termination type (if applicable).